| Execution period | FY 2026-27 |
|---|
BSE filing, NSE: EASTRED. Summary written from the filing by ALFA Finder's alert engine.
Eastern Treads Ltd: key numbers
- Share price
- ₹28.95
- Market cap
- ₹15.15 Cr
- Revenue (annual)
- ₹62.41 Cr
- Net profit (annual)
- ₹0.09 Cr
- P/E (TTM)
- 244.7×Sector 31.4×
- Promoter holding
- 65.48%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eastern Treads Ltd
All →Eastern Treads Other Announcement
Eastern Treads Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, disclosing equity share distribution among various stakeholder categories.
Eastern Treads Management Change
Eastern Treads Ltd announced the re-appointment of Mr. Naiju Joseph and the regularization of appointments for Mr. Navas Meeran and Mr. Karandeep Singh as directors.
Eastern Treads Annual General Meeting
Eastern Treads Ltd held its 33rd Annual General Meeting on September 29, 2026, transacting routine business including the adoption of audited financial statements and director appointments.
Eastern Treads Annual Report
Eastern Treads Ltd has submitted its Annual Report for the financial year 2025-26, along with the notice for its 33rd Annual General Meeting.
Eastern Treads Annual General Meeting
Eastern Treads Ltd has scheduled its 33rd Annual General Meeting for September 29, 2026. The cutoff date for e-voting eligibility is set for September 22, 2026.
Eastern Treads Q1 FY27 Results: Net Loss of ₹0.1 Cr, Loss Narrows
Eastern Treads Ltd reported revenue from operations of ₹16.6 Cr (+17.7% YoY) and a net loss of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.1 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.